C22H26ClN7O2S
488 g/mol
원료의약품위험
Dasatinib
다사티닙
CAS302962-49-8EC801-607-0
용도 분류
원료의약품
화합물 분류
헤테로사이클
주요 용도
의약 원료
Dasatinib is a compound used as an active pharmaceutical ingredient in the manufacturing of pharmaceutical products. It is a small-molecule tyrosine kinase inhibitor with a complex polycyclic structure containing aromatic rings and heterocycles.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 302962-49-8
관련 화합물
강한 관련동일 모체 구조
Dasatinib monohydrate
CAS863127-77-9
active pharmaceutical ingredient
유사구조 유사유사도 0.78
N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(4-nitrosopiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
CAS2135905-86-9
Nitrosamine reference standard for impurity testing
유사구조 유사유사도 0.76
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-4-oxidopiperazin-4-ium-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
CAS910297-52-8
Active pharmaceutical ingredient metabolite
유사구조 유사유사도 0.74
Dasatinib Impurity 47
CAS2468737-88-2
Dasatinib impurity reference standard
참고동일 카테고리
Cyclizine hydrochloride
CAS303-25-3
H1-receptor antagonist antiemetic
참고동일 카테고리
METHENOLONE ENANTHATE
CAS303-42-4
steroid ester
참고동일 카테고리
Clomipramine
CAS303-49-1
active pharmaceutical ingredient
참고동일 카테고리
Cyclobenzaprine
CAS303-53-7
skeletal muscle relaxant active pharmaceutical ingredient
안전 참조
위험
H301Toxic if swallowed
H315Causes skin irritation
H318Causes serious eye damage
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H371May cause damage to organs
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
H410Very toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
InChIKey
ZBNZXTGUTAYRHI-UHFFFAOYSA-N
SMILES
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
동의어 목록 (31)
- 1N1
- D-3307
- PHYRAGO
- Dasatinib (JAN/INN)
- 354825, BMS
- BMS Dasatinib
- BMS-354825 HYDRATE
- Dasatanib
- Dasatinib
- Dasatinib (BMS-354825)
- Dasatinib (Standard)
- Dasatinib - Bio-X trade mark
- Dasatinib anhydrous
- JLTN compound
- Sprycel
- Sprycel (Bristol Meyers)
- anh. dasatinib
- anhydrous dasatinib
- dasatinib (anh.)
- dasatinibum